Today I recieved a empty envelope via USPS, Miller Drive, Jonesborough, TN, USA
3 weeks ago •reported by user-bttnb287 • details
1 year ago •source fda.gov
Recall notice
United States
SCYNEXIS, Inc. is conducting a voluntary nationwide recall of 2 lots of BREXAFEMME® (ibrexafungerp tablets) to the consumer level in the US market due to potential cross contamination with a non- antibacterial ß-lactam drug substance in the ibrexafungerp citrate used to manufacture the BREXAFEMME® tablets. During a review of manufacturing equipment and cleaning activities at a supplier, SCYNEXIS was made aware of potential cross-contamination risk with a non-antibacterial beta-lactam drug substance. To date, SCYNEXIS has not received any reports of adverse events established to be due to the possible beta-lactam cross contamination.3 weeks ago •reported by user-bttnb287 • details
2 weeks ago •reported by user-nfzbf967 • details
16 hours ago •reported by user-mfxwy492 • details
1 week ago •reported by user-nmxmg468 • details
1 week ago •reported by user-rhpr4846 • details
4 days ago •source fda.gov • details
Outbreak
2 weeks ago •reported by user-zvtwz839 • details
3 weeks ago •reported by user-xfpg5454 • details
3 weeks ago •reported by user-bytpm752 • details
1 week ago •reported by user-ppww6198 • details
Search